CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The SARS-CoV-2 NeutraLISA assay supplements the company’s CE-marked QuantiVac ELISA and SARS-CoV-2 Interferon-gamma Release assay, which is expected to be available with the CE mark soon. Used in combination, the assays help evaluate the immune response to SARS-CoV-2 induced through natural infection or vaccination with S1/RBD-based vaccines from multiple angles.
Euroimmun, 973-656-1000
Pages: 1 2